Optipharm옵티팜
153710 · KOSDAQ · ₩153710 · 옵티팜
₩4,375▲ ₩25 (0.57%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 24.7% | 25.0% | 24.9% | 24.2% | 23.2% | 26.2% |
| Operating margin | −7.5% | −10.8% | −12.5% | −15.1% | −21.1% | −31.6% |
| Net margin | −9.5% | −11.2% | −12.0% | −14.0% | −12.8% | −21.6% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +5.6% | +13.8% | +13.0% | +8.5% | +12.3% | — |
| Operating income growth | +26.4% | +1.5% | +6.8% | +22.1% | +25.0% | — |
| Net income growth | +10.1% | −6.1% | +3.3% | −19.2% | +33.6% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −9.0% | −9.5% | −9.0% | −9.0% | −6.8% | −9.9% |
| Return on assets | −5.6% | −5.9% | −5.7% | −6.1% | −5.0% | −7.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 62.8% | 60.5% | 58.5% | 56.2% | 42.0% | 33.0% |
| Net debt to equity | 2.9% | 1.3% | −13.2% | −24.6% | 6.5% | −7.6% |
| Current ratio | 116.3% | 120.7% | 146.7% | 176.5% | 232.6% | 329.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Optipharm / 옵티팜 / 153710 / KRX:153710
Source: KRX statistical information